GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Discovery Laboratories, Inc. (DSCO) [hlAlert]

Rating:
Underperform
DSCO
up 43.33 %

Discovery Laboratories, Inc. (DSCO) rated Underperform with price target $0.12 by Jefferies & Co

Posted on: Monday,  Jul 6, 2009  8:25 AM ET by Jefferies & Co

Jefferies & Co rated Underperform Discovery Laboratories, Inc. (NASDAQ: DSCO) on 07/06/2009, when the stock price was $0.52.
Since then, Discovery Laboratories, Inc. has lost 30.23% as of 01/25/2016's recent price of $0.36.
If you would have followed this Jefferies & Co's recommendation on DSCO, you would have gained 43.33% of your investment in 2394 days.

Discovery Laboratories, Inc., formerly known as Ansan Pharmaceuticals, Inc., is a development-stage pharmaceutical company that focuses on developing compounds to treat respiratory diseases that affect the ability of the lungs to absorb oxygen. It is initially developing its lead product candidate, Surfaxin, for use by newborn infants to treat two respiratory conditions in critical care units of hospitals. The second compound under development is SuperVent, which is intended to treat airway diseases such as cystic fibrosis (CF) and chronic bronchitis.

Our focus on growing and mid-sized companies enables us to identify unique investment ideas, which can make the difference in a tough market. Jefferies' research effort covers U.S. & International equity, high yield, convertibles, investment grade fixed income and post-reorganization securities, as well as special situations and quantitative research. The more than 120-person team of research professionals covers over 1,200 companies in more than 40 industries worldwide. Our analysts focus on identifying emerging industry themes and dig deeper to provide in-depth, thought provoking, objective research. Our analysts use a variety of quantitative and qualitative tools, integrating field analysis, proprietary channel checks and ongoing dialogue with the managements of the companies they cover. We utilize the latest technologies to deliver a research product that is timely, differentiated, and tailored to each customer's needs. Regular client access to companies and their management teams is provided through a wide variety of Jefferies hosted industry conferences, company management meetings and on-site tours.
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy